MedTrace Logo

A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) for the Treatment of External Genital Warts

NCT03158974 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2021-05-03

No results posted yet for this study

Summary

This trial will be a phase 2, open-label, study to evaluate the safety, tolerability, and efficacy of VIR007 when administered topically for up to 60 days to adults between the ages of 18 to 65 years with a clinical diagnosis of external condylomata acuminata.

Conditions

  • Condylomata Acuminata

Interventions

DRUG

East Indian Sandalwood Oil Cream

Cream containing 10% East Indian Sandalwood Oil (EISO)/Albuterpenoids

Sponsors & Collaborators

  • Progressive Clinical Research

    collaborator OTHER

  • ViroXis Corporation

    lead INDUSTRY

Principal Investigators

  • Mark Lee, MD · Progressive Clinical Trials

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-01
Primary Completion
2018-06-17
Completion
2018-06-17
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03158974 on ClinicalTrials.gov